EVOK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases...

Stats
Dzisiejszy wolumen	10 762.00
Średni wolumen	41 178.00
Kapitalizacja rynkowa	4.12M
EPS	$-0.590 ( 2024-03-14 )
Następna data zysków	( $-0.210 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.210
ATR14	$0.0230 (4.60%)

Insider Trading

Date	Person	Action	Amount	type
2023-05-10	Widder Kenneth J	Buy	14 250	Stock Option (Right to Buy)
2023-05-10	Reed Vickie S	Buy	15 000	Stock Option (Right to Buy)
2023-05-10	Hill Malcolm R	Buy	14 625	Stock Option (Right to Buy)
2023-05-10	Garner Cam L	Buy	17 750	Stock Option (Right to Buy)
2023-05-10	Brady Todd C	Buy	14 625	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 99 transactions
Buy: 6 847 814 \| Sell: 1 253 905

Evoke Pharma Inc Korelacja

10 Najbardziej pozytywne korelacje
EBIX	0.956
AGIL	0.954
RIDE	0.954
LGVN	0.953
DRMA	0.952
LMDX	0.951
VRAY	0.951
ASLE	0.951
VMAR	0.95
VVOS	0.946

10 Najbardziej negatywne korelacje
SGII	-0.966
NESR	-0.959
EGLE	-0.946
RNLC	-0.942
VMGA	-0.94
ADAL	-0.938
INBKZ	-0.938
KRUS	-0.934
ORTX	-0.933
SPLK	-0.932

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Evoke Pharma Inc Finanse

Annual	2023
Przychody:	$5.18M
Zysk brutto:	$4.98M (96.10 %)
EPS:	$-2.33

FY	2023
Przychody:	$5.18M
Zysk brutto:	$4.98M (96.10 %)
EPS:	$-2.33

FY	2022
Przychody:	$2.51M
Zysk brutto:	$2.14M (85.24 %)
EPS:	$-2.60

FY	2021
Przychody:	$1.62M
Zysk brutto:	$1.29M (79.72 %)
EPS:	$-3.24

Financial Reports:

No articles found.

Evoke Pharma Inc

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.